Brief: Faes Farma Says Calcifediol Significantly Reduced ICU Admission Risk In COVID-19 Patients
Sept 8 (Reuters) - Faes Farma SA FAE.MC :
* SAYS ADMINISTRATION OF ONE OF ITS PRODUCTS, CALCIFEDIOL
(HYDROFEROL), SIGNIFICANTLY REDUCED RISK OF ICU ADMISSION IN
COVID-19 PATIENTS
Source text for Eikon: ID:nCNM43qcF8
Further company coverage: FAE.MC
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))